Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Rose

Showing results (61-70 of 201) with videos related to

Pageof 21
Sort By:
JCO Precision Oncology|August 18, 2023
Fam-Trastuzumab Deruxtecan in HER2/Neu-Expressing Serous Endometrial CancerPeter G Rose, Johanna A Kelley, Myra Feldman, et al.
Gynecologic Oncology|January 18, 2006
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group studyPeter G Rose, Maurie Markman, Jeffrey G Bell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group studyCharles Kunos, Chunqiao Tian, Steven Waggoner, et al.
Gynecologic Oncology|June 7, 2008
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trialMartee L Hensley, John A Blessing, Robert Mannel, et al.
Journal of Gynecologic Oncology|February 17, 2015
Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasionHaider Mahdi, Amelia Jernigan, Benjamin Nutter, et al.
American Journal of Clinical Oncology|October 8, 2008
A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancerPeter G Rose, Mary Smrekar, Pam Haba, et al.
Gynecologic Oncology Reports|February 9, 2026
Temporary intraperitoneal breast implant spacer to facilitate safe stereotactic body radiotherapy for recurrent high-grade serous ovarian carcinomaCaleigh E Smith, Emilie K Sandfeld, Sheen Cherian, et al.
Gynecologic Oncology|June 12, 2003
Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivityPeter G Rose, Nancy Fusco, Mary Smrekar, et al.
Pharmacotherapy|May 20, 2016
Effect of Prophylactic Extended-Infusion Carboplatin on Incidence of Hypersensitivity Reactions in Patients with Ovarian, Fallopian Tube, or Peritoneal CarcinomasAmy L Pasternak, Nicholas A Link, Carolyn M Richardson, et al.
Anticancer Research|October 30, 2016
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the LiteratureKristen D Starbuck, Richard D Drake, G Thomas Budd, et al.
Pageof 21

Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
JCO Precision Oncology|August 18, 2023
Fam-Trastuzumab Deruxtecan in HER2/Neu-Expressing Serous Endometrial CancerPeter G Rose, Johanna A Kelley, Myra Feldman, et al.
Gynecologic Oncology|January 18, 2006
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group studyPeter G Rose, Maurie Markman, Jeffrey G Bell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group studyCharles Kunos, Chunqiao Tian, Steven Waggoner, et al.
Gynecologic Oncology|June 7, 2008
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trialMartee L Hensley, John A Blessing, Robert Mannel, et al.
Journal of Gynecologic Oncology|February 17, 2015
Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasionHaider Mahdi, Amelia Jernigan, Benjamin Nutter, et al.
American Journal of Clinical Oncology|October 8, 2008
A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancerPeter G Rose, Mary Smrekar, Pam Haba, et al.
Gynecologic Oncology Reports|February 9, 2026
Temporary intraperitoneal breast implant spacer to facilitate safe stereotactic body radiotherapy for recurrent high-grade serous ovarian carcinomaCaleigh E Smith, Emilie K Sandfeld, Sheen Cherian, et al.
Gynecologic Oncology|June 12, 2003
Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivityPeter G Rose, Nancy Fusco, Mary Smrekar, et al.
Pharmacotherapy|May 20, 2016
Effect of Prophylactic Extended-Infusion Carboplatin on Incidence of Hypersensitivity Reactions in Patients with Ovarian, Fallopian Tube, or Peritoneal CarcinomasAmy L Pasternak, Nicholas A Link, Carolyn M Richardson, et al.
Anticancer Research|October 30, 2016
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the LiteratureKristen D Starbuck, Richard D Drake, G Thomas Budd, et al.
Pageof 21